Dr. Kenneth Emancipator, MD, DABP to Give Keynote at GTCbio’s Biomarker Summit
Dr. Kenneth Emancipator will discuss, “Programmed Cell Death 1 Ligand” (PD-L1) as a Companion Diagnostic for Pembrolizumab” at Biomarker Summit. - January 06, 2017
Sherie Morrison, UCLA David Geffen School of Medicine, to Speak at ImmunoTx Summit
Sherie Morrison, Distinguished Professor at UCLA David Geffen School of Medicine, will present, “Antibody Fusions with Interferon for the Treatment of Malignancy” at GTCbio’s ImmunoTx Summit. - November 30, 2016
John Lambert, ImmunoGen to Present at GTCbio’s Antibody Drug Conjugates Conference
John Lambert, Executive Vice President at ImmunoGen, to present at 2nd Antibody Drug Conjugates Conference. - November 18, 2016
Stefan Gluck, VP, Celgene to Speak at GTCbio’s 2nd Cancer Diagnostics Conference (Nov. 2016)
Stefan Gluck, Vice President, Global Medical Affairs at Celgene, to speak at GTCbio’s 2nd Cancer Diagnostics Conference (Nov 7-8, 2016 in San Francisco, CA). - September 09, 2016
Prof. Terry Hébert from McGill University to Present at GPCR in Drug Discovery Conference
Prof. Terry Hébert at McGill University, to talk on, "Assessing Bias and Allostery in GPCRs using Conformational Biosensors" at GPCR Meeting. - August 27, 2016
Eli Gilboa, University of Miami, to Present at 7th Non-Coding RNA & RNAi Therapeutics
Eli Gilboa, Professor of Microbiology & Immunology, University of Miami, to present at 7th Non-Coding RNA & RNAi Therapeutics Conference. - July 28, 2016
Kevin Morris, from the City of Hope, to Present at 7th Non-Coding RNA & RNAi Therapeutics
Kevin Morris, City of Hope, to discuss “Genomic Dark Matter; The Complexities of Non-Coding RNA from Mechanism to Therapeutics” at Non-Coding RNA & RNAi Conference. - July 27, 2016
Marcus Carr, Vice President at Pfizer to Keynote at GTCbio’s Cell & Gene Therapy Conference
Marcus Carr, Vice President at Pfizer, will give a keynote presentation on, “Clinical Development of Gene Therapy for Hemophilia B” at 3rd Cell & Gene Therapy. - July 21, 2016
Michael Egan, Executive Director at Merck, to Present at CNS Diseases World Summit 2016
Michael Egan, Executive Director, Clinical Neuroscience at Merck to present at CNS Diseases World Summit 2016. - July 21, 2016
Hua Xu, Principal Scientist at Pfizer, to Present at Drug Design & Medicinal Chemistry Mtg
Hua Xu, Worldwide Medicinal Chemistry at Pfizer, to discuss “Chemical Biology Tools for Target Identification” at 11th Drug Design & Medicinal Chemistry Mtg. - July 19, 2016
TJ Cradick from CRISPR Therapeutics to Present at GTCbio’s Cell & Gene Therapy Conference
TJ Cradick, Head of Genome Editing at CRISPR Therapeutics, to talk on, “Therapeutic Gene Editing with CRISPR/CAS9” at 3rd Cell & Gene Therapy Mtg - July 14, 2016
Erin Keaney, at Novartis, to Present at Drug Design & Medicinal Chemistry
Erin Keaney, Global Discovery Chemistry at Novartis Institutes for BioMedical Research, will give a presentation at 11th Drug Design & Medicinal Chemistry. - July 12, 2016
Richard Buller, VP at Pfizer, to Give a Keynote at GTCbio’s Biomarker Summit Europe 2016
Richard E. Buller, VP at Pfizer, will give a keynote presentation at GTCbio’s Biomarker Summit Europe 2016. - July 10, 2016
Dr. Stephen Chang to Present at CNS Diseases World Summit 2016
Dr. Stephen Chang, Vice President of R&D at NYSCF will give a presentation at GTCbio’s CNS Diseases World Summit 2016. - July 06, 2016
An Update on Neurodegeneration Panel Discussion at CNS Diseases World Summit
Harry M. Tracy, President of NI Research will lead “An Update on Neurodegeneration...” panel at CNS Diseases World Summit 2016. - July 04, 2016
Michael Naso, Janssen R&D to Present at GTCbio’s Cell & Gene Therapy Conference
Michael Naso, Janssen R&D will discuss, “The Future of Biotherapeutics” at GTCbio’s 3rd Cell & Gene Therapy - June 30, 2016
Judy Lieberman, Harvard Medical School to Keynote at Non-Coding RNA & RNAi Therapeutics
Judy Lieberman, Professor of Pediatrics at Harvard Medical School, will give a keynote presentation at GTCbio’s 7th Non-Coding RNA & RNAi Therapeutics Conference. - June 29, 2016
Diana Colleluori at Bluebird Bio to Present at GTCbio’s Cell & Gene Therapy Conference
Diana Colleluori at Bluebird Bio will discuss, “Quality Control Considerations for Commercialization of Autologous Cell Products” at 3rd Cell & Gene Therapy. - June 26, 2016
Mark Trusheim, MIT, to Present at GTCbio’s Inaugural Precision Medicine Conference
Mark Trusheim, MIT to present, “Implementing Precision Medicine, Determining Economic Value under Adaptive Biomedical Innovation Pathways“ at the Inaugural Precision Medicine Conference. - June 13, 2016
Susan Hager, VP at Foundation Medicine to Present at Inaugural Precision Medicine Conference
Susan Hager at Foundation Medicine will give a presentation on, “Precision Medicine in the Information Age” at GTCbio’s Precision Medicine Conference - June 08, 2016
Robert Weinberg, MIT, to Present at 2nd Cancer Markers & Liquid Biopsies
Robert Weinberg, MIT, will give a presentation, on “Mechanisms of Malignant Progression of Carcinomas” at 2nd Cancer Markers & Liquid Biopsies Conference. - June 01, 2016
Paraskevi Giannakakou, Weill-Cornell Medical College to Present at 2nd Cancer Markers & Liquid Biopsies
Paraskevi Giannakakou, Professor of Pharmacology in Medicine & Principal Investigator at Weill-Cornell Medical College, will give a presentation on, “Drug-Target Engagement in CTCs: From Mechanism to Clinical Application in Prostate Cancer” at GTCbio’s 2nd Cancer Markers &... - May 30, 2016
Johan Skog, CSO at Exosomes Diagnostics to Present at 2nd Cancer Markers & Liquid Biopsies
Johan Skog, CSO at Exosomes Diagnostics, will give a presentation on the current progress in exosome applications at GTCbio’s 2nd Cancer Markers & Liquid Biopsies Conference to be held on July 6-7, 2016 in Boston, MA. Dr. Skog is the Chief Scientific Officer and founding scientist of... - May 07, 2016
Rebecca Leary, Novartis, to Present at 2nd Cancer Markers & Liquid Biopsies
Rebecca Leary from Novartis, will give a presentation on, “Characterizing the Cancer Genome from the Circulation” at GTCbio’s 2nd Cancer Markers & Liquid Biopsies Conference. - April 29, 2016
Helmy Eltoukhy, Guardant Health, to Give Keynote at 2nd Cancer Markers & Liquid Biopsies
Helmy Eltoukhy, Guardant to give Keynote on, “From Wired to Wireless: The Guardant Experience with 20,000+ Clinical Liquid Biopsies” at Cancer Markers Conf. - April 27, 2016
Aaron Black, Inova Health System to speak at GTCbio’s Big Data Bioinformatics Conference
Aaron Black, Director of Informatics at Inova Health Systems will present at GTCbio’s Big Data Bioinformatics Conference to be held on May 25-26, 2016 in Boston, MA. Aaron Black is a thought leader in personalized medicine informatics and a results-driven technical leader with a 15+ year... - April 23, 2016
Michael Seaman of Harvard to Give Keynote at GTCbio’s Antiviral Drugs Conference
Harvard’s Michael Seaman talk is entitled “Choosing Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Infection.” - April 22, 2016
Jeffery Schloss, NHGRI, to Keynote Speak at GTCbio’s 6th Next Generation Sequencing
Jeffery Schloss, Ph.D., NHGRI to discuss “Developing Technologies for the $1,000 Genome–the Path to Today & Beyond” at GTCbio’s 6th Next Generation Sequencing - April 16, 2016
John Doench, Broad Institute, to Speak at GTCbio’s CRISPR & Genome Engineering Conference
John Doench, Associate Director, Genetic Perturbation Platform, Broad Institute of MIT and Harvard, to speak at GTCbio’s CRISPR & Genome Engineering Conference. Since joining the Broad Institute in 2009, John Doench has engaged in dozens of collaborations centered on functional genomics. - April 03, 2016
Howard Federoff, UC Irvine, to Speak at the GTCbio’s Metabolomics Conference
Howard Federoff, UC Irvine, to speak at the GTCbio’s 3rd Metabolomics - Advances & Applications in Human Disease Conference - April 03, 2016
Mark Albrecht, HHS/ASPR/BARDA, to Speak at 13th Anti-Infectives: Partnering & Deal-Making
Mark Albrecht, BARDA, to Present “Expanding Public–Private Partnerships to Strengthen the Antimicrobial Pipeline” at Anti-Infectives Partnering & Deal-Making - April 02, 2016
George Church, Harvard Medical School to Keynote Speak at GTCbio’s Big Data Bioinformatics Conference
George Church at Harvard Medical School will discuss, “New Technologies for Collecting and Interpreting Petabytes for BRAIN and Precision Medicine projects” at GTCbio’s Big Data Bioinformatics conference. - March 30, 2016
Sheng Lin‐Gibson at NIST, to Present at Stem Cell Summit 2016
Sheng Lin‐Gibson, at the National Institute of Standards and Technology of the Federal Agency, will give a presentation at GTCbio’s Stem Cell Summit 2016. - March 17, 2016
Roderick Hubbard, Vernalis to Give Presentation at GTCbio’s Kinase Inhibitors Conference
Roderick Hubbard at Vernalis will discuss, “Strategies and Outcomes for Fragments for Kinases” at GTCbio’s Kinase Inhibitors Design & Screening Conference - March 17, 2016
Roderick Hubbard, Vernalis to Give Presentation at GTCbio’s Med Chem Conference
Roderick Hubbard at Vernalis will discuss, “Strategies and Outcomes for Fragments for Kinases” at GTCbio’s Med Chem Conference. - March 17, 2016
Alex Sherman, Massachusetts General Hospital to Speak at GTCbio’s Big Data Bioinformatics
Alex Sherman at Massachusetts General Hospital will discuss, “Big Data in Rare Diseases” at GTCbio’s Big Data Bioinformatics conference. - March 10, 2016
Jared Cumming, Merck, to Give a Presentation at GTCbio’s Protease Inhibitors Conference
Jared Cumming from Merck will discuss, “Discovery of Verubecestat (MK-8931): A beta-Secretase Inhibitor in Phase 3 Clinical Development for Alzheimer’s Disease.” - February 19, 2016
Je H. Lee from Cold Springs Harbor Laboratory Will Discuss, “Spatial Transcriptomics and Beyond” at GTCbio’s 6th Next Generation Sequencing
Je H. Lee, Assistant Professor at Cold Springs Harbor Laboratory will discuss, “Spatial Transcriptomics and Beyond” at GTCbio’s 6th Next Generation Sequencing to be held on May 25-26, 2016 in Boston, MA. The Lee lab at CSHL is advancing in situ technologies, originally developed... - February 18, 2016
Alan Wright, CMO of Roche Diagnostics, to Keynote at Biomarkers Summit 2016
Alan Wright, CMO of Roche Diagnostics, will give a keynote presentation on, “Creating Personalized Diagnostics Ecosystems” at Biomarkers Summit 2016. - February 18, 2016
Jared Cumming, Merck, to Give a Presentation at GTCbio’s Protease Inhibitors Conference
Jared Cumming from Merck will discuss, “Discovery of Verubecestat (MK-8931): A beta-Secretase Inhibitor in Phase 3 Clinical Development for Alzheimer’s Disease.” - February 11, 2016
Tomi Sawyer at Merck, to Keynote Present at Protein-Protein Interaction, Oct. 23-24, 2014 in Boston
Tomi Sawyer, Distinguished Scientist & Head of Peptide Drug Discovery & Innovative Technologies at Merck will keynote present at 2nd Protein-Protein Interaction Conference to be held on October 23-24, 2014 in Boston, MA by GTC. GTCbio's upcoming 2nd Protein-Protein Interaction Conference... - August 14, 2014
Juhi Juneja, Bristol-Myers Squibb to Speak at Protein-Protein Interaction, Oct. 23-24, 2014 in Boston
Juhi Juneja, Senior Research Investigator at Bristol-Myers Squibb to Speak at 2nd Protein-Protein Interaction Conference, October 23-24, 2014 in Boston, MA. - July 22, 2014
Mark Bunnage to Speak at Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston)
Mark Bunnage, Vice President, Head of Chemistry Biotherapeutics Research at Pfizer to Give a Keynote Presentation at the 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA) - July 13, 2014
Jianxin Zhang, Sanofi Pasteur, to Speak at Protein-Protein Interaction, Oct. 23-24, 2014 in Boston
Jianxin Zhang, Deputy Director of Protein Characterization at Sanofi Pasteur to Speak at 2nd Protein-Protein Interaction Conference, October 23-24, 2014 in Boston, MA. - July 06, 2014
Nic Angell at Amgen to Speak at Protein Expression, Purification, Characterization Oct 23-24, 2014
Nic Angell, Principal Scientist, Process Development at Amgen to Speak at Protein Expression, Purification & Characterization Conference, October 23-24, 2014 in Boston, MA. - July 05, 2014
Igor Kaltashov, Univ. of Massachusetts-Amherst to Speak at Protein Expression Oct 23-24, 2014 Boston
Igor Kaltashov, Professor and Graduate Program Director of Chemistry at the University of Massachusetts-Amherst to Speak at Protein Expression, Purification & Characterization Conference, October 23-24, 2014 in Boston, MA. - July 05, 2014
Nathanael Gray to Speak at 3rd Protein Kinases & Drug Design Conference (October 23-24, 2014 in Boston, MA)
Nathanael Gray, Professor, Biological Chemistry and Molecular Pharmacology, Dana Farber Cancer Institute, Harvard Medical School to Give a Featured Presentation at the 3rd Protein Kinases & Drug Design Conference (Oct 23-24, 2014 in Boston, MA). - July 05, 2014
Robert Murphy Speaks at Cell Based Assay Conf., Oct 7-8, 2014, Dublin, Ireland
Robert Murphy, Carnegie Mellon University, to Give Keynote Address at Cell Based Assay & Screening Technologies Conference, October 7-8, 2014 in Dublin, Ireland. - June 22, 2014
Special Big Pharma Panel to be Held at CNS Diseases Summit, Sept 18-19, 2014, SF
Panel discussion on “What Sells Big Pharma in CNS Diseases?” to be held at the CNS Diseases World Summit, Sept. 18-19, 2014 in San Francisco, CA - June 19, 2014
Kathleen Coelingh, MedImmune to Speak at Influenza R&D Conference on July 9-11, 2014, in Boston, MA
Kathleen Coelingh, Senior Director, Medical Affairs at MedImmune to Give a Presentation on, “Development of Pandemic Live Attenuated Influenza Vaccines” at the 3rd Annual Influenza Research and Development Conference on July 9-11, 2014, in Boston, MA, by GTCbio. Dr. Coelingh will... - June 19, 2014